This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Benign neoplasm: Eye, unspecified
CD2_EYE_NOS
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
154 |
4. Check minimum number of eventsNone |
154 |
5. Include endpointsNone |
154 |
6. Filter based on genotype QC (FinnGen only) |
154 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D31
- Name in latin
- Neoplasma benignum oculi non specificatum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Eye, unspecified
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm: Eye, unspecified
- Benign neoplasm of eye and adnexa
- Benign neoplasm of eye and adnexa
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 154 | 100 | 54 |
| Unadjusted period prevalence (%) | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | 57.05 | 55.43 | 60.05 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 141
- Matched controls
- 1411
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D31.9
ICD-10 Finland
Benign neoplasm: Eye, unspecified
+∞
138.2
109
*
CBB30
NOMESCO Finland
Excision of lesion of eyelid
13.5
11.8
20
17
2240A
ICD-9 Finland
Benign neoplasm of eye, Eyeball, except conjunctiva, cornea, retina and choroid
+∞
10.5
10
*
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
59.1
9.8
11
*
2248X
ICD-9 Finland
Benign neoplasm of eye, Other specified parts of eye
+∞
8.4
8
*
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
7.3
7
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
6.9
38
143
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
73.0
6.5
7
*
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
+∞
6.3
6
*
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
8.3
6.3
13
17
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
23
123
2.02
2.26
2.1
1.9
1.3
1.4
%
0.33
18
108
29
176
1.80
1.98
3.6
2.7
26.0
23.1
%
0.26
24
152
8
27
3.07
1.96
1.4
1.2
—
—
—
0
0
67
521
1.51
1.69
4.0
4.1
62.4
42.2
ng/l
0.24
38
371
82
665
1.50
1.68
9.8
6.7
1.2
1.2
mmol/l
0.56
70
564
8
31
2.67
1.68
1.4
1.3
—
—
—
0
0
5
14
3.65
1.63
1.6
1.3
—
—
—
0
0
6
20
3.08
1.59
1.5
1.6
—
—
—
0
0
6
21
2.93
1.52
1.5
1.7
—
—
—
0
0
112
980
1.52
1.51
3.7
4.1
15.1
14.9
pmol/l
0.32
98
879
45
331
1.51
1.45
1.6
1.5
18.2
21.6
nmol/l
0.91
34
271
6
23
2.67
1.38
2.0
1.8
—
—
—
0
0
8
36
2.29
1.26
1.5
2.1
—
—
—
0
0
6
25
2.45
1.25
1.5
1.8
—
—
—
0
0
21
133
1.67
1.25
5.3
3.7
—
—
—
0
0
88
751
1.40
1.24
16.2
9.9
3.4
4.0
e9/l
2.99
82
660
8
37
2.22
1.23
1.4
1.9
—
—
—
0
0
56
446
1.40
1.17
6.1
3.5
2.3
2.4
mmol/l
1.32
48
394
28
199
1.50
1.05
2.1
2.0
—
—
—
0
0
5
22
2.31
1.04
1.0
1.0
—
—
—
0
0
5
22
2.31
1.04
1.6
1.8
—
—
—
0
0
5
23
2.21
0.99
2.2
1.8
253.8
258.3
u/ml
—
5
15
133
1245
1.50
0.93
4.5
4.7
5.9
6.0
mmol/l
0.05
120
1131
8
43
1.91
0.89
1.6
1.9
—
—
—
0
0
6
30
2.04
0.88
1.5
1.9
—
—
—
0
0
31
235
1.40
0.85
4.3
3.6
629.6
96.0
ng/l
0.50
25
181
36
283
1.36
0.80
2.8
2.3
1.1
1.0
mg/l
0.13
28
225
14
91
1.59
0.78
3.5
5.5
440.0
294.2
ng/l
0.32
14
79
7
39
1.83
0.73
2.1
1.6
—
—
—
0
0
9
57
1.61
0.72
4.7
2.2
—
—
—
0
0
62
533
1.27
0.72
2.3
2.0
89.2
95.2
pmol/l
0.42
33
273
9
58
1.59
0.71
2.6
2.0
—
—
—
0
0
7
41
1.74
0.71
1.0
1.5
—
—
—
0
0
140
1341
1.48
0.67
22.1
17.1
84.0
76.5
umol/l
1.24
140
1341
69
607
1.25
0.65
9.3
5.6
1.2
1.2
mmol/l
0.50
61
549
17
122
1.44
0.63
11.5
4.0
1.9
2.4
mmol/l
0.28
11
95
121
1139
1.29
0.60
25.0
15.3
38.2
39.6
%
0.86
86
827
8
53
1.54
0.59
2.0
1.7
—
—
—
0
0
12
81
1.52
0.59
1.9
1.6
—
—
—
0
0
105
974
1.25
0.59
5.2
4.1
16.3
12.8
mm/h
1.18
99
883
18
134
1.39
0.56
1.9
1.8
—
—
—
0
0
11
156
0.68
0.53
8.9
8.0
—
—
—
0
0
125
1190
1.27
0.50
4.7
4.8
1.8
1.9
mu/l
0.87
115
1075
30
360
0.79
0.49
1.7
1.6
1.2
1.4
mmol/l
0.75
21
300
31
368
0.80
0.47
4.6
3.9
0.0
0.0
estimate
0.00
15
130
126
1208
1.24
0.42
18.5
13.7
78.4
78.9
ml/min/173m2
0.08
111
1000
0
15
0.00
0.41
0.0
1.3
—
10.1
—
0
15
59
532
1.18
0.40
2.2
2.4
80.3
77.5
nmol/l
0.34
51
463
0
19
0.00
0.39
0.0
1.4
—
235.8
—
0
19
31
264
1.22
0.39
4.4
4.3
21.5
20.1
%
0.16
15
129
31
264
1.22
0.39
2.0
1.7
1003.8
1149.7
nmol/l
0.26
20
204
9
71
1.28
0.37
1.8
1.8
—
—
—
0
0
6
41
1.48
0.36
1.0
1.2
—
—
—
0
0
6
43
1.41
0.35
1.7
2.0
—
—
—
0
0
17
136
1.28
0.35
2.0
2.0
—
—
—
0
0
14
173
0.79
0.30
5.8
4.7
31.6
32.5
%
—
8
112
23
196
1.20
0.29
3.2
3.0
0.8
0.7
ug/l
0.22
16
136
12
94
1.30
0.29
6.1
7.3
4.9
5.0
kpa
0.16
12
84
65
604
1.13
0.28
4.6
4.2
—
—
—
0
0
144
1413
1.29
0.26
31.1
21.6
130.8
133.9
g/l
1.66
144
1387
9
77
1.18
0.25
1.8
3.8
4.6
4.4
pmol/l
—
9
68
5
37
1.36
0.24
1.2
1.1
—
—
—
0
0
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
8
102
0.77
0.22
1.5
1.7
—
—
—
0
0
5
42
1.20
0.21
11.0
3.0
186.0
195.4
%
—
5
42
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
5.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
82
782
1.10
0.21
3.4
2.9
—
—
—
0
0
0
14
0.00
0.20
0.0
4.2
—
96.5
—
0
14
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
13.9
—
0
14
6
51
1.18
0.19
2.2
1.9
—
—
—
0
0
37
340
1.12
0.19
3.5
3.0
356.8
7144.5
umol/l
1.73
31
288
12
141
0.84
0.17
9.0
4.4
0.6
0.9
mmol/l
—
7
109
19
213
0.88
0.16
1.2
1.3
53.4
8.3
u/ml
—
6
73
23
208
1.12
0.15
2.7
3.1
2.0
2.8
e6/l
0.26
13
119
36
384
0.92
0.13
3.5
3.0
0.2
0.5
e6/l
0.61
26
290
28
302
0.91
0.13
3.9
2.3
—
—
—
0
0
46
481
0.94
0.10
3.5
3.2
—
—
—
0
0
24
223
1.09
0.10
2.6
2.8
0.7
1.2
e6/l
0.39
14
132
5
46
1.09
0.09
2.0
1.5
—
—
—
0
0
68
659
1.06
0.09
6.1
5.3
0.0
0.0
estimate
0.00
16
137
50
520
0.94
0.09
4.6
4.0
—
—
—
0
0
6
54
1.12
0.09
3.0
2.2
—
—
—
0
0
6
55
1.09
0.09
1.8
3.2
15.7
2557.9
u/ml
—
6
47
7
65
1.08
0.08
6.1
2.4
1.1
1.2
%
—
7
65
80
781
1.05
0.08
6.5
4.0
6.8
6.5
mmol/l
0.52
75
726
12
108
1.12
0.07
3.1
1.6
—
—
—
0
0
7
83
0.84
0.07
1.4
1.3
—
—
—
0
0
11
121
0.90
0.06
3.8
1.7
—
—
—
0
0
121
1197
1.05
0.05
6.4
5.7
40.3
39.9
mmol/mol
0.14
111
1114
128
1291
0.95
0.04
20.9
14.6
20.4
24.1
mg/l
0.60
105
1033
22
230
0.95
0.03
1.1
1.2
18.8
32.3
iu/ml
0.94
12
77
20
209
0.95
0.03
1.5
1.4
—
—
—
0
0
125
1241
1.04
0.02
4.8
4.6
4.8
4.7
mmol/l
0.54
114
1147
121
1202
1.03
0.02
4.3
4.0
1.3
1.3
mmol/l
0.19
107
1097
67
662
1.02
0.01
4.2
3.8
0.0
0.0
estimate
0.00
16
135
29
283
1.03
0.01
1.2
1.2
7.2
1.3
u/ml
—
8
79
123
1236
0.98
0.00
4.8
4.5
1.5
1.5
mmol/l
0.14
109
1130
11
106
1.04
0.00
8.9
3.5
1.3
1.4
mmol/l
0.18
11
101
127
1269
1.00
0.00
5.5
5.1
2.9
2.7
mmol/l
1.02
116
1161
28
281
1.00
0.00
2.1
1.8
414.7
477.3
pmol/l
0.58
23
235
22
223
0.98
0.00
1.4
1.4
—
—
—
0
0
67
665
1.01
0.00
4.3
3.9
0.0
0.0
estimate
0.00
16
126
55
549
1.00
0.00
10.0
4.8
34.4
35.5
g/l
0.76
50
517
86
856
1.01
0.00
3.7
3.0
48.9
44.4
u/l
0.20
77
799
0
6
0.00
0.00
0.0
2.5
—
16.8
—
0
6
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
0
6
0.00
0.00
0.0
1.0
—
103.8
—
0
6
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
6
67
0.89
0.00
3.0
3.8
54.8
46.7
%
—
6
67
0
9
0.00
0.00
0.0
3.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
8.9
—
0
8
0
8
0.00
0.00
0.0
3.6
—
61.6
—
0
8
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
7
69
1.02
0.00
1.6
1.3
—
—
—
0
0
6
66
0.91
0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_EYE_NOS – Benign neoplasm: Eye, unspecified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).